227 related articles for article (PubMed ID: 33278965)
21. CD44-Targeted Multifunctional Nanomedicines Based on a Single-Component Hyaluronic Acid Conjugate with All-Natural Precursors: Construction and Treatment of Metastatic Breast Tumors
Fang H; Zhao X; Gu X; Sun H; Cheng R; Zhong Z; Deng C
Biomacromolecules; 2020 Jan; 21(1):104-113. PubMed ID: 31532629
[TBL] [Abstract][Full Text] [Related]
22. Zein nanoparticles as nontoxic delivery system for maytansine in the treatment of non-small cell lung cancer.
Yu X; Wu H; Hu H; Dong Z; Dang Y; Qi Q; Wang Y; Du S; Lu Y
Drug Deliv; 2020 Dec; 27(1):100-109. PubMed ID: 31870183
[No Abstract] [Full Text] [Related]
23. Preparation and Evaluation of Cabazitaxel-Loaded Bovine Serum Albumin Nanoparticles for Prostate Cancer.
Wan Z; Xie F; Wang L; Zhang G; Zhang H
Int J Nanomedicine; 2020; 15():5333-5344. PubMed ID: 32801692
[TBL] [Abstract][Full Text] [Related]
24. PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells.
Afsharzadeh M; Hashemi M; Babaei M; Abnous K; Ramezani M
J Cell Physiol; 2020 May; 235(5):4618-4630. PubMed ID: 31674023
[TBL] [Abstract][Full Text] [Related]
25. Synergistic anticancer activity of combined histone deacetylase and proteasomal inhibitor-loaded zein nanoparticles in metastatic prostate cancers.
Thapa RK; Nguyen HT; Jeong JH; Shin BS; Ku SK; Choi HG; Yong CS; Kim JO
Nanomedicine; 2017 Apr; 13(3):885-896. PubMed ID: 27993720
[TBL] [Abstract][Full Text] [Related]
26. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
[TBL] [Abstract][Full Text] [Related]
27. Characterization and bioactivity of self-assembled anti-angiogenic chondroitin sulfate-ES2-AF nanoparticle conjugate.
Xing L; Sun F; Wang Z; Li Y; Yang Z; Wang F; Zhai G; Tan H
Int J Nanomedicine; 2019; 14():2573-2589. PubMed ID: 31040673
[TBL] [Abstract][Full Text] [Related]
28. Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo.
Feng L; Wu H; Ma P; Mumper RJ; Benhabbour SR
Int J Nanomedicine; 2011; 6():2545-56. PubMed ID: 22072889
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
30. Chondroitin sulfate derived theranostic and therapeutic nanocarriers for tumor-targeted drug delivery.
Khan AR; Yang X; Du X; Yang H; Liu Y; Khan AQ; Zhai G
Carbohydr Polym; 2020 Apr; 233():115837. PubMed ID: 32059890
[TBL] [Abstract][Full Text] [Related]
31. Fabrication of compact zein-chondroitin sulfate nanocomplex by anti-solvent co-precipitation: Prevent degradation and regulate release of curcumin.
Shi Y; Rong S; Guo T; Zhang R; Xu D; Han Y; Liu F; Su J; Xu H; Chen S
Food Chem; 2024 Jan; 430():137110. PubMed ID: 37562259
[TBL] [Abstract][Full Text] [Related]
32. Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice.
Bao X; Qian K; Yao P
J Nanobiotechnology; 2020 Apr; 18(1):67. PubMed ID: 32345323
[TBL] [Abstract][Full Text] [Related]
33. Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery.
Wang H; Wu J; Williams GR; Fan Q; Niu S; Wu J; Xie X; Zhu LM
J Nanobiotechnology; 2019 May; 17(1):60. PubMed ID: 31084622
[TBL] [Abstract][Full Text] [Related]
34. Chondroitin sulfate modified chitosan nanoparticles as an efficient and targeted gene delivery vehicle to chondrocytes.
Moghadam NA; Bagheri F; Eslaminejad MB
Colloids Surf B Biointerfaces; 2022 Nov; 219():112786. PubMed ID: 36049252
[TBL] [Abstract][Full Text] [Related]
35. Comparative efficacy of chloramphenicol loaded chondroitin sulfate and dextran sulfate nanoparticles to treat intracellular Salmonella infections.
Kiruthika V; Maya S; Suresh MK; Kumar VA; Jayakumar R; Biswas R
Colloids Surf B Biointerfaces; 2015 Mar; 127():33-40. PubMed ID: 25645750
[TBL] [Abstract][Full Text] [Related]
36. Chondroitin sulfate-functionalized polyamidoamine as a tumor-targeted carrier for miR-34a delivery.
Chen W; Liu Y; Liang X; Huang Y; Li Q
Acta Biomater; 2017 Jul; 57():238-250. PubMed ID: 28511876
[TBL] [Abstract][Full Text] [Related]
37. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
[TBL] [Abstract][Full Text] [Related]
38. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
da Rocha MCO; da Silva PB; Radicchi MA; Andrade BYG; de Oliveira JV; Venus T; Merker C; Estrela-Lopis I; Longo JPF; Báo SN
J Nanobiotechnology; 2020 Mar; 18(1):43. PubMed ID: 32164731
[TBL] [Abstract][Full Text] [Related]
39. Drug delivery systems based on CD44-targeted glycosaminoglycans for cancer therapy.
Li M; Sun J; Zhang W; Zhao Y; Zhang S; Zhang S
Carbohydr Polym; 2021 Jan; 251():117103. PubMed ID: 33142641
[TBL] [Abstract][Full Text] [Related]
40. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
